KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $342.4 million.

  • BioNTech SE's Other Non-Current Assets rose 1305.01% to $342.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $342.4 million, marking a year-over-year increase of 1305.01%. This contributed to the annual value of $227.3 million for FY2024, which is 2479.6% down from last year.
  • BioNTech SE's Other Non-Current Assets amounted to $342.4 million in Q3 2025, which was up 1305.01% from $243.4 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Other Non-Current Assets peaked at $386.9 million during Q2 2024, and registered a low of $49.7 million during Q2 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $237.3 million (2023), whereas its average is $227.8 million.
  • In the last 5 years, BioNTech SE's Other Non-Current Assets surged by 1078043.56% in 2021 and then tumbled by 3710.13% in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Other Non-Current Assets stood at $129.7 million in 2021, then rose by 26.46% to $164.0 million in 2022, then soared by 84.24% to $302.2 million in 2023, then dropped by 24.8% to $227.3 million in 2024, then surged by 50.65% to $342.4 million in 2025.
  • Its Other Non-Current Assets was $342.4 million in Q3 2025, compared to $243.4 million in Q2 2025 and $246.5 million in Q1 2025.